Chemistry & Industry Press Release for Issue 24 - Cover Date 17 DecemberDecember 14, 2001NEWS US Chemicals heading toward trade deficit (p783) The US is set to slide into its first trade deficit since the 1920s next year and the Republic of Ireland will run close to Canada in the race to be the largest exporter to the US in value terms. Cartels face EUR135M fines (p783) Citric acid producers Roche, Archer Daniels Midland, Jungbunzlauer, Haarman & Reimer and Cerestar, have been fined for fixing the price and market of this food additive. Cloning fallout-resignation (p784) One of the editorial advisers on e-biomed: The Journal of Regenerative Medicine has resigned following the decision by the journal to publish details of the world's first human clone. More clones and clones of clones (p785) A spate of claims to have successfully cloned animals has been followed by a claim by an American company to have cloned hundreds of farm animals and to have even cloned clones. Reversing stem cells to aid therapy (p786) Scientists have discovered the mechanism that controls the specialisation of cells, opening up the possibility of producing stem cells for fully matured adult cells. BUSINESS Biotechnology declares war on recession (p788) While most industries are battening down the hatches to see out the financial storms, biotechnology is thriving. Maria Burke explores the impact of changes in government funding to the biotech industry following the bioterrorism attacks in the US, and what the biotech industry can do to help by re-focusing its research efforts. FEATURES Festive Cheer - shaken, not stirred (p795) George Kauffman investigates the Martini: its contribution to the study of solution concentration problems in chemistry; its status as a cultural icon; and the continuing debate of whether `shaken or stirred` versions of the drink are more beneficial to health. Chocolate - candy is dandy (p803) Maybe this Christmas you can feel less guiltily as you as over-indulge on chocolates as evidence emerges about the beneficial effects of chocolate and cocoa on the heart. Harold Schmitz presents a defence of chocolate and the active ingredients that confer these beneficial effects. DRUG DISCOVERY - a Chemistry & Industry Special The great and the small (p798) John Morris, head of KPMG`s pharmaceuticals practice, investigates the growing trend among big pharmaceutical companies for collaborations and outsourcing in order to maintain double-digit growth. A winning combination (p799) Angelo De Palma discusses the impact of combinatorial chemistry on the pharmaceutical industry and where the technology can go from here in order to increase the number of drug molecules found. Turn the problem on its head (p802) Claire Curran reports on Structural GenomiX, a US biotech company developing technology to discover drug molecules using 3-D protein models, as an alternative to the high-throughput technology. For advance PDF pages please contact Kelly Quigley E: kelly.quigley@soci.org; T@ +44 (0) 20 7598 1573 Society of Chemical Industry |
|||||||||||||||||||||
| Related Stem Cells Current Events and Stem Cells News Articles New discovery about the formation of new brain cells The generation of new nerve cells in the brain is regulated by a peptide known as C3a, which directly affects the stem cells' maturation into nerve cells and is also important for the migration of new nerve cells through the brain tissue, reveals new research from the Sahlgrenska Academy published in the journal Stem Cells. Umbilical cord blood stem cell transplant may help lung, heart disorders Two separate studies published in the current issue of Cell Transplantation (18:8), - now freely available on-line have shown that transplanted human-derived umbilical cord blood (UCB) stem cells transplanted in an animal model had positive therapeutic effects on specific lung and heart disorders the animal models. Gene mismatch influences success of bone marrow transplants A commonly inherited gene deletion can increase the likelihood of immune complications following bone marrow transplantation, an international team of researchers reports in the November 22 advance online issue of Nature Genetics. New research shows versatility of amniotic fluid stem cells For the first time, scientists have demonstrated that stem cells found in amniotic fluid meet an important test of potential to become specialized cell types, which suggests they may be useful for treating a wider array of diseases and conditions than scientists originally thought. First reconstitution of an epidermis from human embryonic stem cells Stem cell research is making great strides. This is yet again illustrated by a study carried out by the I-STEM* Institute (I-STEM/ Inserm UEVE U861/AFM), published in the Lancet on 21 November 2009. The I-STEM team, directed by Marc Peschanski has just succeeded in recreating a whole epidermis from human embryonic stem cells. Bone Implant Offers Hope for Skull Deformities A synthetic bone matrix offers hope for babies born with craniosynostosis, a condition that causes the plates in the skull to fuse too soon. Your Own Stem Cells Can Treat Heart Disease The largest national stem cell study for heart disease showed the first evidence that transplanting a potent form of adult stem cells into the heart muscle of subjects with severe angina results in less pain and an improved ability to walk. The transplant subjects also experienced fewer deaths than those who didn't receive stem cells. Is hepatic differentiation of embryonic stem cells induced by valproic acid and cytokines? Embryonic stem (ES) cells, known for their capacity to proliferate indefinitely and differentiate into almost all types of cells including hepatocytes, have raised the hope of cellular replacement therapy for liver failure. Paradoxical protein might prevent cancer One difficulty with fighting cancer cells is that they are similar in many respects to the body's stem cells. By focusing on the differences, researchers at Karolinska Institutet have found a new way of tackling colon cancer. The study is presented in the prestigious journal Cell. U of M researchers find 2 units of umbilical cord blood reduce risk of leukemia recurrence A new study from the Masonic Cancer Center, University of Minnesota shows that patients who have acute leukemia and are transplanted with two units of umbilical cord blood (UCB) have significantly reduced risk of the disease returning. More Stem Cells Current Events and Stem Cells News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||